
FDA•LOW
Povidone Iodine/Proparacaine Ophthalmic Solution
Imprimis NJOF recalls ophthalmic solution for being subpotent, risking reduced efficacy.

Imprimis NJOF recalls ophthalmic solution for being subpotent, risking reduced efficacy.

Ajanta Pharma recalls Fluphenazine HCl 1mg tablets (NDC 27241-255-01) due to impurity out-of-specification.

Trokendi XR (topiramate) 50 mg capsules recalled over failed dissolution specs.

New York Blood Center recalls apheresis red blood cells over incorrect anticoagulant ratio.

Bionpharma recalls Doxylamine Succinate and Pyridoxine HCl 10 mg/10 mg tablets over foreign tablets or capsules.

Safecor recalls Ibuprofen oral suspension syringes over cross-contamination risk.

Central Admixture recalls pediatric TPN bags due to incorrect formulation.

Red Cross recalls Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced units lacking required yield testing.

Ascend recalls Dabigatran Etexilate 75mg/150mg capsules over impurity spec failures.
6 products
Lidolog Kit is being recalled because the label wrap obscures the barcode, making it difficult to scan.
2 products
Supernus recalls Trokendi XR 25mg capsules over failed dissolution specs.
3 products
Ascend recalls Dabigatran etexilate capsules (110 mg, 150 mg) over impurity test failures.
2 products
Ohm Laboratories is recalling 180 mg Fexofenadine Hydrochloride tablets due to failed impurities and degradation specifications.

ANI Pharmaceuticals is recalling Hydroxyzine Hydrochloride Oral Solution, 10 mg/5 mL, due to the presence of a foreign substance.
